HRMY Q4 2020 Earnings — Harmony Biosciences Holdings, Inc. Revenue & Financial Results | Market Cap Arena

HRMYHarmony Biosciences Holdings, Inc.

$2B

Q4 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$56M+838.9% YoY

Gross Profit

$46M82.4% margin

Operating Income

$8M13.8% margin

Net Income

-$208,000-0.4% margin

EPS (Diluted)

$-0.00

QoQ Revenue Growth

+23.4%

Cash Flow

Operating Cash Flow

$10M

Free Cash Flow

$10M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$427M

Total Liabilities

$330M

Stockholders' Equity

$97M

Cash & Equivalents

$229M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$56M	$6M	+838.9%
Gross Profit	$46M	$4M	+949.6%
Operating Income	$8M	-$34M	+123.0%
Net Income	-$208,000	-$36M	+99.4%